Ipratropium bromide/salbutamol
Ipratropium bromide/salbutamol, a wɔtɔn no wɔ din Combivent mu, yɛ aduru a wɔde di dwuma de sa akwahosan mu yareɛ (COPD)[1][2][3]. Emu bi ne ipratropium (anticholinergic) ne salbutamol (albuterol, β2-adrenergic agonist)[1].
Nea ɛtaa ba no bi ne kɔn mu yaw, ntini mu ntini, ne ayamhyehye[1]. Akwanhyia afoforo bi ne bronchospasm, nsunsuanso bɔne, ne mframa mu yare[1]. Nnyinsɛn mu ahobammɔ ho nsɛm nnyina hɔ pefee.[4]
Baabi a menyaa mmoa firiiɛ
[sesa]- ↑ 1.0 1.1 1.2 1.3 DailyMed - COMBIVENT RESPIMAT- ipratropium bromide and albuterol spray, metered, retrieved 2024-08-26
- ↑ BNF 76: September 2018, British National Formulary (september 2018 - march 2019 ed.), London: Pharmaceutical Press, 2018, ISBN 978-0-85711-338-2
{{citation}}:|access-date=requires|url=(help) - ↑ Joshiah Gordon, Ralph J Panos (2010-03), "Inhaled albuterol/salbutamol and ipratropium bromide and their combination in the treatment of chronic obstructive pulmonary disease", Expert Opinion on Drug Metabolism & Toxicology (in English), vol. 6, no. 3, pp. 381–392, doi:10.1517/17425251003649549, ISSN 1742-5255, retrieved 2024-08-26
{{citation}}: Check date values in:|date=(help) - ↑ Albuterol / ipratropium Use During Pregnancy (in English), retrieved 2024-08-26